Lidocaïne Vaselinecrème Tiofarma

Lidocaine, the active ingredient in Lidocaïne Vaselinecrème Tiofarma, is a local anesthetic presented as a vaseline cream for rectal use. It provides topical pain relief and is employed in conditions such as hemorrhoids, anal fissures and other sources of local rectal discomfort.

GNH USA supplies Lidocaïne Vaselinecrème Tiofarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is a local anesthetic that blocks peripheral nerve sodium channels to relieve pain in several anorectal conditions.

Hemorrhoids: reduces pain and discomfort associated with hemorrhoidal disease. Anal fissures: provides topical analgesia that facilitates healing of fissures. Local pain relief: alleviates minor rectal irritation or procedural discomfort.

Lidocaine cream may cause local and systemic reactions, ranging from mild irritation to rare severe events.

Common Side Effects: - Mild skin irritation at the application site - Burning or stinging sensation - Itching or pruritus - Redness or erythema - Swelling or edema - Dryness of the treated area

Serious or Rare Side Effects: - Allergic reactions such as urticaria or angioedema - Severe dermatitis or contact eczema - Systemic toxicity presenting as CNS symptoms (dizziness, seizures) - Methemoglobinemia (rare) - Cardiovascular disturbances (arrhythmia, hypotension)

When using Lidocaïne Vaselinecrème Tiofarma, follow these safety measures.

Application: apply a thin layer only to the affected rectal area. Avoid: do not use on extensive broken skin or mucosa beyond the intended site. Contraindication: discontinue if known hypersensitivity to lidocaine or other amide anesthetics. Pregnancy: safety not established; use only if potential benefit outweighs risk. Children: exercise caution in pediatric patients and adjust usage as directed. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lidocaine can interact with other medicines that affect sodium channels or its metabolism.

Major Interactions (Avoid): - Concurrent use with other topical anesthetics containing lidocaine (risk of cumulative toxicity). - Co‑administration with class I antiarrhythmics (e.g., quinidine) may increase systemic lidocaine levels. - Strong CYP3A4 inhibitors could raise systemic exposure.

Moderate Interactions (Monitor Closely): - Use with other sodium‑channel blockers (e.g., mexiletine) may have additive effects. - Combination with vasoconstrictors may alter local absorption. - Caution when combined with other drugs that lower seizure threshold.